Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Accured Expenses (2016 - 2025)

IGC Pharma has reported Change in Accured Expenses over the past 13 years, most recently at $93000.0 for Q3 2025.

  • Quarterly Change in Accured Expenses fell 70.57% to $93000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.2 million through Sep 2025, down 344.05% year-over-year, with the annual reading at -$196000.0 for FY2025, 199.49% down from the prior year.
  • Change in Accured Expenses was $93000.0 for Q3 2025 at IGC Pharma, up from -$599000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $484000.0 in Q1 2023 and troughed at -$599000.0 in Q2 2025.
  • The 4-year median for Change in Accured Expenses is $59500.0 (2021), against an average of -$3714.3.
  • Year-over-year, Change in Accured Expenses surged 236.17% in 2024 and then crashed 496.69% in 2025.
  • A 4-year view of Change in Accured Expenses shows it stood at -$30000.0 in 2021, then crashed by 793.33% to -$268000.0 in 2023, then increased by 19.4% to -$216000.0 in 2024, then skyrocketed by 143.06% to $93000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Change in Accured Expenses are $93000.0 (Q3 2025), -$599000.0 (Q2 2025), and -$447000.0 (Q1 2025).